Research, Select, & Monitor Thursday, March 22, 2018 11:20:54 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup
Edwards Lifesciences Corp.$139.35$.28.20%

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Edwards Lifesciences Corp. vs Diagnostic Substances

Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards Lifesciences Corporation is headquartered in Irvine, California.

Be they in the hardware development side or the chemical development side, these companies have the same goal; to increase the disease detection threshold and to increase the productivity of labs so more tests can be performed in less time. Each company tends to go about this goal in a different way. One company is involved heavily in gene testing and therapy, another is in manufacturing better isotopes to be used in nuclear medicine. Also, some companies have their hand in the home-testing fields for such things as Human Immunodeficiency Virus (HIV, the virus that causes AIDS) and other diseases.
 Totals Company Industry
  Sales: $3,435.3 Mil $9,481.6 Mil
  Market Cap: $29,430.0 Mil $71,252.7 Mil
  Analysts Recommendation: Strong Buy Buy

 Averages Company Industry
  Historic Revenue: 15.9% 12.5%
  Estimated Revenue: 12.1% 14.6%
  Historic Earnings: 31.5% 6.2%
  Estimated Earnings: 16.7% 9.9%
  Stock Price (1 Year): 49.8% 33.7%
  Cash per Share: (9.9%) 18.8%
  Dividend: N/A N/A
  Trailing PE: N/A N/A
  Forward PE: 27.4 40.3
  Price-to-Sales: 8.6 N/A
  Price-to-Book: 10.0 (18.7)
  Dividend Yield: N/A N/A
  Market Cap: $29,430.0 Mil $3,238.8 Mil
  Net Margin: 17.0% (237.9%)
  Gross Margin: 74.5% 63.4%
  Return on Equity: .2 (.2)
  Return on Assets: .1 (.2)
  Balance Sheet
  Current Ratio: 1.8 3.8
  Quick Ratio: 1.4 3.1
  Cash Ratio: 1.0 2.2
  Debt-to-Equity: .9 1.0
  Interest Coverage: (5.2) (1.5)
  Relative-Strength Index: 57.4 N/A

 Other companies in Diagnostic Substances Price Market Cap
  IDEXX Laboratories, Inc.  (IDXX) $200.23 $17,464.1 Mil
  DexCom Inc  (DXCM) $67.71 $5,884.0 Mil
  Neogen Corp.  (NEOG) $64.92 $3,373.3 Mil
  NuVasive Inc.  (NUVA) $51.40 $2,619.9 Mil
  Immunomedics, Inc.  (IMMU) $15.37 $2,374.5 Mil

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2018 All rights reserved.